Germany
Dirk Winkler is leading Hit Identification at Evotec, a global function operating at various European and US sites. He started his industrial career in 1998 at Evotec. Dirk was involved and responsible for building and expanding various areas supporting drug discovery at Evotec. This includes Evotec’s biophysics and label free screening platform and other emerging technologies. He also is passionate about further developing Evotec’s screening collections. In his current role, he is in charge of Evotec’s global screening strategy and capabilities, covering a wide range of approaches and technologies from traditional target directed Hit ID, structure based, biophysical and label free approaches as well as phenotypic screens.
Disclosure information not submitted.
Strategies Accelerating the Identification of High-Quality Hit Series
Tuesday, February 6, 2024
2:00 PM – 3:00 PM EST